Mesothelioma Talcum Powder Lawsuit Trial Concludes In New Jersey
Mesothelioma Talcum Powder Lawsuit Trial Concludes In New Jersey: One more trial regarding mesothelioma caused by a talcum powder concludes as New Jersey Jury Awards $37 Million to Mesothelioma Complainant, Bernstein Liebhard.
Imery’s Talc America along with Johnson & johnson has been ordered to pay $37 million to a New Jersey man who was diagnosed with mesothelioma following years of talcum powder use.
Law suit involving Imery’s Talc followed for more than two months of testimony marked the first time a Plaintiff’s claim that in a talcum powder there is a presence of asbestos that cause often deadly form of cancer. In the course of the trial, jurors were shown numerous internal documents indicating that, as early as 1969, the Defendants were concerned that Baby Powder could be contaminated by asbestos.
The 7-person jury considered for less than a day before finding Imery’s Talc America 30% liable for the Plaintiff’s damages, while Johnson & Johnson was found 70% liable. Jurors will further decide whether the companies should be assessed any disciplinary damages.
Bernstein Liebhard LLP, a nationwide law firm is representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated Johnson & Johnson’s talc-based powders.
More than 6,600 talcum powder lawsuits have been filed against the talcum powder on behalf of women who were diagnosed with ovarian cancer following years of genital talc use. Plaintiffs involved in this litigation have cited numerous studies published since the 1970s suggesting that the regular and repeated application of talc-based powders to the female genitals increased a woman’s risk for the deadly disease.
The complaints also gave numerous internal documents as evidence that the officials of Imery’s talc were aware of this fact of having harmful substance in their product but chose not to warn consumers in order to protect profits derived from sales of its Baby Powder and Shower-to-Shower products.
California completed its first talcum powder ovarian cancer trial in September, when a Los Angeles Superior Court jury awarded the Plaintiff $417 million, including $340 million in punitive damages. However, that verdict was later dismissed by the trial judge.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP has all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, their attorneys and legal staff have been able to recover more than $3.5 billion on behalf of their clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal’s “Plaintiff’s Hot List,” recognizing the top plaintiff’s firms in the country. This year’s nomination marks the thirteenth year the firm has been named to this prestigious annual list.
For More Information & Videos Subscribe To Our YouTube Channel